271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145

261 trials found

diseases per page:

Showing 1 to 10 of 261 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05257174 (ClinicalTrials.gov)	March 2022	28/1/2022	The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis	A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Jing Si Herbal Tea L ...	Arthritis;Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Fatigue	Dietary Supplement: Jing Si Herbal Tea LIQUID PACKETS;Dietary Supplement: Placebo	Buddhist Tzu Chi General Hospital	NULL	Not yet recruiting	20 Years	99 Years	All	150	N/A	Taiwan
2	NCT04924270 (ClinicalTrials.gov)	January 2022	7/6/2021	Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diag ...	Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatmen ...	Rheumatoid Arthritis;Reactive Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Gouty Arthritis;P ...	Biological: Faecal microbiota transplantation;Other: Placebo	Torkell Ellingsen	Region of Southern Denmark;University of Southern Denmark	Not yet recruiting	18 Years	70 Years	All	200	Phase 2	NULL
3	NCT05212051 (ClinicalTrials.gov)	December 10, 2021	30/11/2021	Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients Wi ...	A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Prelimin ...	Active Ankylosing Spondylitis	Biological: JS005;Biological: Placebo	Shanghai Junshi Bioscience Co., Ltd.	Sponsor GmbH	Recruiting	18 Years	65 Years	All	120	Phase 2	China
4	NCT04947579 (ClinicalTrials.gov)	August 25, 2021	23/6/2021	A Study of CC-99677 in Participants With Active Ankylosing Spondylitis	A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evalu ...	Spondylitis, Ankylosing	Drug: CC -99677;Other: Placebo	Celgene	NULL	Recruiting	18 Years	65 Years	All	256	Phase 2	United States;Canada;Czechia;Germany;Poland;Romania;Russian Federation;Spain;Turkey
5	NCT04795141 (ClinicalTrials.gov)	August 24, 2021	3/3/2021	ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety a ...	Ankylosing Spondylitis	Drug: ABY-035;Drug: Normal saline	Inmagene Biopharmaceuticals	Affibody	Recruiting	18 Years	N/A	All	300	Phase 2	Cayman Islands
6	EUCTR2019-004108-37-DE (EUCTR)	09/07/2021	18/02/2021	A study to determine how effective and safe the drug CC-99677 is for patients with active Ankylosing ...	A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evalu ...	Ankylosing Spondylitis MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylosing ...	Product Code: CC -99677 60mg Capsule INN or Proposed INN: 146368 Other descriptive name: CC -99677 Product ...	Celgene Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	256	Phase 2	United States;Czechia;Canada;Spain;Poland;Romania;Turkey;Russian Federation;Germany
7	NCT04934059 (ClinicalTrials.gov)	July 1, 2021	8/6/2021	Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).	A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy ...	Ankylosing Spondylitis	Drug: Yuxuebi tablet;Drug: Placebo tablet	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	NULL	Not yet recruiting	18 Years	65 Years	All	60	Phase 4	China
8	NCT04840485 (ClinicalTrials.gov)	June 9, 2021	7/4/2021	Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis	A Randomized, Double-blind, Multicenter, Placebo-controlled, Phase II/III Adaptive Study of SHR-1314 ...	Ankylosing Spondylitis	Drug: SHR-1314;Drug: Placebo	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	NULL	Recruiting	18 Years	N/A	All	529	Phase 2/Phase 3	China
9	EUCTR2019-001684-77-HU (EUCTR)	07/12/2020	08/12/2020	A trial to test whether BI 730357 is effective in patients with active ankylosing spondylitis	A 12-weeks Phase II, randomized, double-blind, placebocontrolled, parallel-group, proof-of-concept t ...	axial spondyloarthritis MedDRA version: 21.1;Level: LLT;Classification code 10041672;Term: Spondylit ...	Product Code: BI 730357 INN or Proposed INN: BI 730357 Other descriptive name: BI 730357	Boehringer Ingelheim RCV GmbH & Co KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	United States;Czechia;Hungary;Spain;Belgium;Ukraine;Romania;Georgia;Germany;Moldova, Republic of;Kor ...
10	NCT04507659 (ClinicalTrials.gov)	December 2020	4/8/2020	Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis	A Multi-center, Randomized, Double-blind, Placebo, Parallel-controlled Phase ? Clinical Trial of Jak ...	Ankylosing Spondylitis	Drug: Jaktinib Hydrochloride Tablets;Drug: Placebo	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	NULL	Not yet recruiting	18 Years	65 Years	All	105	Phase 2	NULL

First Previous1 2 3 4 5…27Next Last